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Abstract The yi-isoform of protein phosphatase-1 expressed in 
EsderiBia coli (PP17) and the native PPl catalytic subunit 
(PPlC) isolated from skeletal muscle dephosphorylated Ser-14 
of glycogen phosphorylase at comparable rates. In contrast, 
PPly dephosphorylated several tyrosine-phosphorylated proteins 
at similar rates to authentic protein tyrosine phosphatases 
(PTPases), but native PPlC was almost inactive towards these 
substrates. The phosphorylase phosphatase (PhP) and PTPase 
activities of PPly were inhibited by vanadate with ICsa values 
(30-100 PM) comparable to authentic PTPases, whereas the 
PhP activity of native PPlC was insensitive to vanadate. PPly 
lost its PTPase activity, and its PhP activity became insensitive 
to vanadate, after interaction with inhibitor-2, followed by the 
reversible phosphorylation of inhibitor-2 at Thr-72. These 
findings support and extend the hypothesis that inhibitor-2 
functions like a chaperone to fold PPl into its native 
conformation, and suggest that the correct folding of PPl may 
be critical to prevent the uncontrolled dephosphorylation of 
cellular phosphotyrosine residues. 
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1. Introduction 
Protein phosphatase-1 (PPl), one of the major serine/threo- 
nine-specific protein phosphatases in eukaryotic cells, is inhib- 
ited specifically by two small thermostable proteins termed 
inhibitor-l and inhibitor-2 [l]. Inhibitor-l only becomes a 
PPl inhibitor after it has been phosphorylated by cyclic 
AMP-dependent protein kinase and is likely to play a role 
in the regulation of PPl by agonists that modulate the cellular 
concentration of cyclic AMP. In contrast, the phosphoryla- 
tion of inhibitor-2 (at Thr-72), which is catalysed by glycogen 
synthase kinase-3 (GSK3) and several other kinases in vitro, is 
not required to inhibit PPl but essential to initiate reactiva- 
tion of the PPl-inhibitor-2 complex (hereafter termed PPlI) 
VI. 
A new hypothesis for the role of PPlI emerged while study- 
ing the properties of PPl expressed in E. coli [3]. Four iso- 
forms of the PPl catalytic subunit have been identified in 
mammalian cells, termed PPla, PPlp and PPlyi and PPlys. 
When expressed in E. coli, several of the properties of PPla, 
PPlp and PPlyi were found to resemble those of the ‘native’ 
PPl catalytic subunit extracted from mammalian tissues, 
while others were quite different. For example, ‘expressed’ 
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and ‘native’ forms of PPl had a similar activity towards gly- 
cogen phosphorylase and similar sensitivity to inhibitor-2, but 
the activity of ‘expressed’ PPl towards histone Hl (phos- 
phorylated at Ser/Thr-Pro motifs by a cyclin-dependent pro- 
tein kinase) was far higher. Moreover, ‘expressed’ forms of 
PPl were lOO-lOOO-fold less sensitive to inhibitor-l, PPlcl 
and PPlyi were unable to interact with the M-subunits that 
target PPl to myosin and PPlp was less sensitive to inhibition 
by naturally occurring toxins, such as okadaic acid and mi- 
crocystin-LR [3]. However, when ‘expressed’ forms of PPl 
were combined with inhibitor-2 and Thr-72 was reversibly 
phosphorylated, the properties reverted to those of ‘native’ 
PPl. Taken together, these observations suggested that inhib- 
itor-2 might play an important role in the correct folding of 
PPl in vivo. 
The concept that inhibitor-2 may function in a manner 
analogous to a ‘chaperone’ or ‘matchmaker’ has been ques- 
tioned [4,5] but, in this paper, we present further evidence in 
support of this hypothesis. We show that while ‘native’ PPl is 
devoid of protein tyrosine phosphatase (PTPase) activity, 
PPly expressed in E. coli is an extremely active PTPase. More- 
over, the PTPase activity is lost when ‘expressed’ PPl is com- 
bined with inhibitor-2 and Thr-72 reversibly phosphorylated. 
We suggest that the reversible phosphorylation of inhibitor-2 
is not only essential to fold PPl correctly, but is likely to be 
critical to prevent the uncontrolled dephosphorylation of cel- 
lular phosphotyrosine residues. 
2. Materials and methods 
2.1. Materials 
PPlC and the glycogen-bound form of PPl (PPlG) were purified 
from rabbit skeletal muscle [6]. Human PPln [7], PPla and PPlB 
were expressed in E. coli and purified [3] by Drs. D. Alessi and A. 
Street (MRC Protein Phosphorylation Unit, Dundee). Inhibitor-2 was 
purified from rabbit skeletal muscle by Dr. M. Hubbard (MRC Pro- 
tein Phosphorylation Unit, Dundee) [8]. PTP-PEST was purified as 
described [9]. The c-Fgr protein tyrosine kinase (TPK-III) and the 
synthetic peptide AFLEDFFTSTEPQYQPGENL corresponding to 
residues 514533 of p60src (except for Phe in place of Tyr at residue 
6) [lo] (termed src-tide) were gifts from Professor L. Pinna and Dr. 
Maria Ruzzene (University of Padua, Italy). 
2.2. Preparation of 32P-labelled substrates and protein phosphatase 
assays 
“‘P-labelled glycogen phosphorylase, phosphorylated at Ser-14 by 
phosphorylase kinase [6], and 32P-labelled casein, phosphorylated at 
serine residues by cyclic AMP-dependent protein kinase [11], were 
prepared as described previously. The src-tide peptide (see Section 
2.1) was phosphorylated at the tyrosine residue by cFgr protein tyr- 
osine kinase in the presence of polylysine [lo], and myelin basic pro- 
tein (MBP) and yeduced-carboxymethylated !ysozyme (RCML) were - 
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“2P-labelled on tyrosine using the P-subunit of the insulin receptor as 
the tyrosine kinase [12]. 
All PPI preparations were assayed at 30°C in the absence of diva- 
lent cations [6,11]. The final substrate concentrations in terms of 32P- 
radioactivity were: phosphorylase (10 PM), casein (6 PM), src-tide 
(0.8 PM), MBP (1 PM) and RCML (1 PM). The para-nitrophenyl 
phosphatase (pNPP) concentration was 5 mM [6]. Caffeine (5 mM) 
was included when the substrate was glycogen phosphorylase [6]. One 
unit of activity (U) was that amount which released 1 pmol of phos- 
phate from each substrate in 1 min. 
3. Results 
3.1. PPly expressed in E. coli has high PTPase activity 
While investigating the possibility of developing a non- 
radioactive assay for PPl, we noticed that the para-nitrophen- 
yl phosphatase (pNPP) activity of bacterially expressed PPly 
was 30-fold higher than that of the native catalytic subunit of 
PPl (PPlC) purified from rabbit skeletal muscle and about 
lOOO-fold higher than that of the glycogen-associated form of 
PPl (PPlG) isolated from the same tissue (Table 1). Since the 
dephosphorylation of a phenolic residue is akin to the dephos- 
phorylation of a tyrosyl residue, we examined the activity of 
different PPl preparations towards several substrates phos- 
phorylated on tyrosine residues. These experiments revealed 
that the PTPase activity of PPly was also remarkably high, 
the rate of dephosphorylation of MBP being slightly higher 
than that of one authentic PTPase (PTP-PEST) towards the 
same substrate (Fig. 1). As observed with pNPP as substrate, 
PPly dephosphorylated a tyrosine-phosphorylated peptide 
substrate (src-tide) 20-fold more rapidly than PPIC and 
lOOO-fold more rapidly than PPlG (Table 1). 
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Fig. 1. Comparison of protein tyrosine phosphatase activity and in- 
hibitor sensitivities of PPly and PTP-PEST. Enzymes were assayed 
in the absence (filled bars) or presence of 1 FM okadaic acid 
(hatched bars), 10 ~.LLM okadaic acid (stippled), 1 mM vanadate (hor- 
izontal lines) or 10 mM vanadate (open), using MBP or RCML 
phosphorylated on tyrosine as substrate. Results are expressed as a 
percentage of the ‘control activity’ (mU/mg) measured in the ab- 
sence of inhibitor, represent the means of duplicate assays and are 
typical of several experiments. 
than native PPlC. This high casein phosphatase activity was 
also lost when PPly was incubated with inhibitor-2 and then 
incubated with GSK3 and MgATP (Table I). 
3.2. Inhibition of bacterially expressed PPly by vanadate and 
okadaic acid 
It is well established that the dephosphorylation of tyrosine 
residues by authentic PTPases is inhibited by vanadate, 
whereas the dephosphorylation of serine and threonine resi- 
dues by native PPlC is not (Fig. 2). Surprisingly, however, we 
found that both the phosphorylase phosphatase (PhP) (Fig. 2) 
and PTPase activities (Fig. 1) of PPly were sensitive to vana- 
date with I& values (0.1 mM for the PhP activity and 0.03 
mM for the src-tide-PTPase activity) similar to those of 
authentic PTPases. Both the PhP [3] and PTPase activities 
of PPly were inhibited by okadaic acid, whereas PTP-PEST 
was completely insensitive to this toxin (Fig. 1). 
We have also noticed that the properties of ‘native’ PPlC 
gradually revert to those of ‘expressed’ PPly during prolonged 
storage at -20°C or after brief exposure to 50 mM NaF. 
These preparations can also be converted to ‘native’ PPlC 
by incubation with inhibitor-2, GSK3 and MgATP (data 
not shown). 
4. Discussion 
3.3. Conversion of bacterially expressed PPIy to a 
serinelthreonine-specific, vanadate-insensitive enzyme 
PPly was incubated with inhibitor-2 and the PPlI thus 
generated was incubated with MgATP and GSK3 to trigger 
the reversible phosphorylation of inhibitor-2 at Thr-72. This 
procedure abolished the PTPase and pNPP activities of PPly 
(Table 1) without affecting the PhP activity [3]. Moreover, the 
PhP activity was now insensitive to vanadate (not shown), like 
native PPlC (Fig. 2). 
3.4. The dephosphorylation of casein by bacterially expressed 
PPly 
In addition to its high activity towards tyrosine phospho- 
rylated substrates, bacterially expressed PPly also dephos- 
phorylated casein (phosphorylated at serine residues by cyclic 
AMP-dependent protein kinase) at a 3&40-fold higher rate 
The data presented here and in [3] (see also Section 1) have 
revealed remarkable differences between bacterially ‘ex- 
pressed’ PPly and ‘native’ forms of PPl extracted from mam- 
malian tissues. Although ‘expressed’ and ‘native’ PPl have a 
similar specific activity towards glycogen phosphorylase and 
are inhibited by the same concentration of inhibitor-2 [3], 
‘expressed’ PPl has a much broader specificity, not only de- 
phosphorylating tyrosine residues as high rates (Table 1, Fig. 
1) but also some serine and threonine residues such as those in 
histone Hl (phosphorylated at SerlThr-Pro motifs) [3] and 
casein (Table 1) that are dephosphorylated extremely poorly 
by ‘native’ PPl. The ‘expressed’ PPla and PPlj3 isoforms also 
had high activity towards all substrates tested (not shown). 
Unlike ‘native’ PPl, ‘expressed’ PPl was inhibited by vana- 
date (Fig. 2), a relatively specific inhibitor of ‘authentic’ 
PTPases. It should be emphasised that the experiments per- 
formed in this paper were carried out in the absence of diva- 
lent cations, although essentially the same differences between 
‘expressed’ and ‘native’ PPl were observed in the presence of 
0.5 mM MnC12 (data not shown). The differences reported 
here do not result from ‘native’ PPl being assayed in the 
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absence and ‘expressed’ PPI in the presence of Mn2+, as sug- 
gested in [5]. 
The data are consistent with a model in which the catalytic 
subunit of PPl exists in at least two conformations, termed 
‘native’ and ‘expressed’. The ‘native’ conformation is the form 
which exists in vivo, while the ‘expressed’ conformation is 
adopted when PPl is expressed in E. coli. ‘Expressed’ PPl 
can be converted to ‘native’ PPI in vitro by combination 
with inhibitor-2 followed by the reversible phosphorylation 
[3] of inhibitor-2 at Thr-72 (Table 1). No other PPl-binding 
protein so far tested [3] can mimic the effect of inhibitor-2, 
suggesting that the ability to convert ‘expressed’ to ‘native’ 
PPl is likely to be one of the physiological roles of inhibi- 
tor-2. The correct folding of PPl is clearly critical to prevent it 
from dephosphorylating many proteins that are not physiolo- 
gical substrates, including many phosphotyrosyl-containing 
proteins, and to enhance or permit interaction with important 
regulators, such as inhibitor-l and targetting subunits [3]. The 
pleiotropic effects of loss-of-function mutations in Glc8p (the 
putative homologue of inhibitor-2 in S. cerevisiae) are consist- 
ent with such a role [13]. It will be interesting to examine 
whether PPl extracted from yeast that lack Glc8 has a high 
PTPase activity. 
A possible explanation for the more restricted specificity of 
native PPl compared with expressed PPl is a conformational 
change in the vicinity of the catalytic site that allows access of 
the phosphoseryl and phosphothreonyl residues but sterically 
prevents binding of the more bulky phosphotyrosine side 
chains. This would also explain the loss of sensitivity towards 
vanadate of the native form as the large ionic radius of vana- 
date may exclude its binding to the native form, but not to the 
more open catalytic site of expressed PPl. 
10 100 loo0 
Vanadate [p&l] 
The catalytic (C) subunit of PP2A (a serinelthreonine-spe- 
cific phosphatase related to PPl) is complexed to an A-sub- 
unit in vivo, while the A-subunit interacts with a variety of ‘B- 
type’ subunits (reviewed in [14]). The AC complex (but not 
ABC complexes) is transformed into a very active PTPase 
upon incubation with MgATP and a protein termed PTPA 
(‘protein iyrosine Ehosphatase activator’) through an un- 
known mechanism that does not-involve phosphorylation of 
either the A or the C-subunit [lS]. This enhancement of the 
Fig. 2. Inhibition of PPly and PPlC by vanadate. PPlC and PPly 
were assayed for phosphorylase phosphatase (PhP) or src-tide phos- 
phatase (src-tideP), and in the presence of the indicated concentra- 
tions of vanadate. 
Table 1 
Specific activities of forms of PPl towards different substrates 
Condition Form of PPl Specific activities (mU/mg) towards 
Ph casein pNPP src-tide 
I PPlC 36000 108 72 126 
PPlG 8 000 40 <4 <4 
PPly 15000 2690 2150 2710 
II PPlC 40 000 28 <l 4 
PPly 40 000 116 t1 <l 
Assays were performed in the absence of Mr?+ ions using phospho- 
rylase a (Ph), casein, para-nitrophenylphosphate (pNPP), or src-tide 
as substrate. In I, PPIC and PPIG (the glycogen-bound form of PPl) 
were from rabbit skeletal muscle, and PPln was expressed in E. coli 
and purified according to Alessi et al. [3]. In II, the enzymes were first 
converted to PPII by preincubation with inhibitor-2 and the inactive 
complexes purified by gel filtration. PPlI was then activated by pre- 
incubation with MgATP and GSK3 prior to assay (see Section 2). 
Because the protein concentrations were too low to measure accu- 
rately after gel filtration, the tabulated PhP activities for condition 
II are quoted from [3] and were close to our estimates based on the 
recovery of activity. 
PTPase activity of PP2A has been suggested as a potential 
mechanism for regulating (as yet unidentified) phosphotyro- 
sine containing proteins, but it should be recalled that the 
effect of PTPA can be mimicked by NaF [16] which also 
converts ‘native’ PPl to ‘expressed’ PPl. An alternative hy- 
pothesis, suggested by the present results, is that PTPA con- 
verts ‘native’ PP2A to a conformation resembling that of ‘ex- 
pressed’ PPl, and that one role for the B-type subunits in vivo 
is to protect PP2A against the ‘deforming’ effects of PTPA, 
whose real physiological role might be unrelated to effects on 
PP2A. It would clearly be interesting to know whether, like 
PPl, PP2A is initially synthesised in the ‘expressed’ conforma- 
tion and whether a protein analogous to inhibitor-2 is re- 
quired to induce the ‘native’ conformation. 
In summary, the present study not only supports and ex- 
tends the hypothesis that inhibitor-2 acts as a ‘chaperone’ or 
‘matchmaker’ to ensure the correct folding of PPl, but has 
emphasised two further points that are of technical relevance 
for the study of this important enzyme. Firstly, when ex- 
pressed in E. coli, PPl is not a serinelthreonine-specific phos- 
phatase, and investigators who are purchasing this enzyme 
from a commercial source need to be aware of its high PTPase 
activity and the abnormally high rates at which it dephos- 
phorylates other substrates. Secondly, the three dimensional 
structures of PPl that have been reported so far [17,18] de- 
scribe the ‘expressed’ and not the ‘native’ conformation, and 
to understand why ‘native’ PPl is unable to dephosphorylate 
238 
tyrosine residues, it will be important, therefore, to solve the 
structure of ‘native’ PPl. 
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